| scholarly article | Q13442814 |
| P2093 | author name string | Jason Behary | |
| Vivek Kumbhari | |||
| P2860 | cites work | Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis | Q22252609 |
| Long-term mortality after gastric bypass surgery | Q28241874 | ||
| Surgical treatment of obesity--weighing the facts | Q28253364 | ||
| Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
| Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 | Q29555853 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| Bariatric surgery: a systematic review and meta-analysis | Q30769299 | ||
| Aspiration therapy leads to weight loss in obese subjects: a pilot study | Q33630723 | ||
| Morbid obesity rates continue to rise rapidly in the United States | Q34300286 | ||
| Meta-analysis: pharmacologic treatment of obesity | Q34408897 | ||
| Balancing risk and reward: a critical review of the intragastric balloon for weight loss | Q34472399 | ||
| Transoral mucosal excision sutured gastroplasty: a pilot study for GERD and obesity with two-year follow-up | Q34503927 | ||
| Bariatric surgery and long-term control of morbid obesity | Q35020501 | ||
| Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials | Q35024182 | ||
| Four‐Year Weight Losses in the Look AHEAD Study: Factors Associated With Long‐Term Success | Q35242207 | ||
| Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight | Q36553542 | ||
| Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders | Q36608638 | ||
| Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study | Q36987037 | ||
| Evidence-based review of the Bioenterics intragastric balloon for weight loss | Q37196280 | ||
| Role of endoscopy in the bariatric surgery patient | Q37199447 | ||
| Bariatric surgery: risks and rewards | Q37311431 | ||
| Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis | Q37409707 | ||
| Bariatric surgery: a systematic review and network meta-analysis of randomized trials. | Q37857901 | ||
| Bariatric Surgery Outcomes | Q37952843 | ||
| Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial | Q37969495 | ||
| Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity | Q38040919 | ||
| The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes | Q38085804 | ||
| The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review | Q38167689 | ||
| Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population | Q42185330 | ||
| Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity | Q42261438 | ||
| Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry | Q42638070 | ||
| Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates | Q42653582 | ||
| A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery | Q43254450 | ||
| Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments | Q44210107 | ||
| A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity | Q44971964 | ||
| Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. | Q45934584 | ||
| Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study | Q46168092 | ||
| Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study | Q46688558 | ||
| First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve | Q46803732 | ||
| Randomized trial of lifestyle modification and pharmacotherapy for obesity | Q46807914 | ||
| Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery | Q47190314 | ||
| Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats | Q47237137 | ||
| Long-term weight regain after gastric bypass: a 5-year prospective study | Q47238719 | ||
| A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: A five-year follow-up | Q47302793 | ||
| Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner | Q47313681 | ||
| Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. | Q47388162 | ||
| Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner | Q48229536 | ||
| Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes | Q48552784 | ||
| BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. | Q50482823 | ||
| Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video). | Q50649545 | ||
| Treatment of Obesity by Endoscopic Gastric Intramural Injection of Botulinum Toxin A: A Randomized Clinical Trial | Q51363543 | ||
| Long-term follow-up of patients' status after gastric bypass | Q53476963 | ||
| Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects | Q53665703 | ||
| Degradation of five polyurethane gastric bubbles following in vivo use: SEC, ATR-IR and DSC studies | Q68039279 | ||
| Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity | Q68153070 | ||
| A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity | Q69750094 | ||
| Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity | Q74581846 | ||
| Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study | Q79151053 | ||
| Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients | Q80923434 | ||
| Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study | Q81493606 | ||
| Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome | Q82783119 | ||
| Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study | Q82868074 | ||
| Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity | Q84613810 | ||
| Endoscopic sleeve gastroplasty for the treatment of obesity | Q85929839 | ||
| Adjustable Intragastric Balloon vs Non-Adjustable Intragastric Balloon: Case–Control Study on Complications, Tolerance, and Efficacy | Q86483988 | ||
| A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels | Q86972616 | ||
| The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial | Q87464651 | ||
| Prevalence of obesity in the United States | Q95426690 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 757821 | |
| P577 | publication date | 2015-05-28 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Gastroenterology research and practice | Q26853898 |
| P1476 | title | Advances in the Endoscopic Management of Obesity | |
| P478 | volume | 2015 |
| Q36236099 | Aspiration therapy for obesity; a safe and effective treatment |
| Q38698582 | Current and cutting-edge interventions for the treatment of obese patients |
| Q41999658 | Endoluminal weight loss and metabolic therapies: current and future techniques |
| Q64083334 | Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists |
| Q57494426 | Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy |
Search more.